glp-1 drug news The revolution: What UAB researchers are discovering about how these drugs work Crackdown on bootleg GLP-1 drugs

The World Obesity Atlas 2024 reports over 1.5 billion projected cases by 2035, highlighting its growing threat among pediatric and adult populations globally

In this Review, the possibilities for utilizing GLP-1 receptor agonists in individualized treatment for type 2 diabetes mellitus are discussed

Albert, MBA, PharmD, JD, DASPL

Purpose of Review GLP-1 receptor agonists (GLP-1RAs) have become central therapies for obesity and metabolic disease

Looking for a safe, affordable way to lose weight with real results

The lead study author and doctors share how these unknown side effects can impact your training and the best ways to adjust your workout routine when taking a GLP-1.